Meet 52 richest Indians in Pharma Healthcare domain
New Delhi: The pharmaceutical sector minted the most number of dollar billionaires with 36 entrepreneurs in the recently released IIFL Wealth Hurun India Rich List 2022.
IIFL Wealth in association with Hurun India launched the 11th annual ranking of the richest individuals in India- IIFL Wealth Hurun India Rich List 2022. As per the list, India's rich cumulatively constitute Rs 100 lakh crore of wealth in 2022.
The founder of Serum Institute of India (SII), nicknamed 'Vaccine King of India', Cyrus S Poonawalla has topped the list among pharma entrepreneurs with 25 percent change in his total wealth to Rs 2,05,400 crore.
Poonawalla (81) has moved to the third rank in the IIFL Wealth Hurun India Rich List 2022 after his wealth increased by 25% or Rs 41,700 crore in the last year. His privately held company is the world's biggest vaccine maker and has recently developed the country's first cervical cancer shot that will hit the market soon. Apart from COVID shots, the SII's Indian plants make vaccines for diphtheria, BCG, measles, rubella and other conditions. He is also considering setting up its first manufacturing plant in Africa as he looks to expand globally.
Ranking second on the list among pharma and health sector is pharma tycoon Dilip Shanghvi with 12 percent change in wealth to Rs 1,33,500 crore. Shanghvi (66), who is the founder and head of India's largest drug maker Sun Pharmaceutical Industries, moved up two ranks to the ninth rank with his wealth increasing by 12% to Rs 1,33,500 crore. In the last five years, his wealth has moved up by 50% or Rs 43,800 crore as the pharma major expanded its global operations.
Meanwhile, 'Biotech Queen' Kiran Mazumdar Shaw has been overthrown by founder of Nykaa, Falguni Nayar and her rank slipped to 67th position with wealth of Rs 24,800 crore.
The pharma sector contributed the highest to the list with 126 entries and India is now an acknowledged supplier of generic drugs to the world. There are 8 new additions to the list while 12 lost the status to be featured in the list. The pharma industry has also greatly benefited from the pandemic-induced need for vaccines and increased focus on drugs. Four from the pharmaceutical sector lost their dollar billionaire status. There are 56 individuals in the list deriving their wealth from listed pharma companies, of which 79% saw their wealth declining cumulatively by Rs 93,400 crore.
IIFL Wealth Hurun India Rich List 2022 – Insights from the Pharma and Health Sector
Rank | Name | Wealth INR Cr | Company | Industry |
1 | Cyrus S Poonawalla & family | 2,05,400 | Serum Institute of India | Pharmaceuticals |
2 | Dilip Shanghvi | 1,33,500 | Sun Pharmaceutical Industries | Pharmaceuticals |
3 | Murali Divi & family | 56,200 | Divi's Laboratories | Pharmaceuticals |
4 | B Parthasaradhi Reddy & family | 39,200 | Hetero Labs | Pharmaceuticals |
5 | Pankaj Patel & family | 34,900 | Zydus Lifesciences | Pharmaceuticals |
6 | Samir Mehta & family | 27,000 | Torrent Pharmaceuticals | Pharmaceuticals |
6 | Sudhir Mehta & family | 27,000 | Torrent Pharmaceuticals | Pharmaceuticals |
7 | Kiran Mazumdar-Shaw | 24,800 | Biocon | Pharmaceuticals |
8 | Mahendra Prasad | 24,700 | Aristo Pharmaceuticals | Pharmaceuticals |
9 | Leena Gandhi Tewari | 19,600 | USV | Pharmaceuticals |
10 | Yusuf Hamied & family | 18,500 | Cipla | Pharmaceuticals |
11 | Manju D Gupta & family | 16,100 | Lupin | Pharmaceuticals |
12 | M Satyanarayana Reddy & family | 16,000 | MSN Laboratories | Pharmaceuticals |
13 | Binish Hasmukh Chudgar & family | 15,300 | Intas Pharmaceuticals | Pharmaceuticals |
13 | Nimish Hasmukh Chudgar & family | 15,300 | Intas Pharmaceuticals | Pharmaceuticals |
13 | Urmish Hasmukh Chudgar & family | 15,300 | Intas Pharmaceuticals | Pharmaceuticals |
14 | PV Ramprasad Reddy | 14,400 | Aurobindo Pharma | Pharmaceuticals |
15 | Satish Ramanlal Mehta & family | 13,500 | Emcure Pharmaceuticals | Pharmaceuticals |
16 | Girdharilal Bawri & family | 12,800 | Macleods Pharmaceuticals | Pharmaceuticals |
17 | Basudeo Narain Singh & family | 12,600 | Alkem Laboratories | Pharmaceuticals |
18 | Arvind Lal & family | 12,500 | Dr. Lal PathLabs | Healthcare |
19 | Banwarilal Bawri & family | 12,500 | Macleods Pharmaceuticals | Pharmaceuticals |
19 | Rajendra Agarwal | 12,500 | Macleods Pharmaceuticals | Pharmaceuticals |
20 | K Satish Reddy & family | 11,300 | Dr. Reddy's Laboratories | Pharmaceuticals |
21 | Gangadhar Motiram Warke & family | 1,400 | Hi Media Laboratories | Pharmaceuticals |
21 | LV Subba Reddy & family | 1,400 | Virchow Laboratories | Pharmaceuticals |
21 | M Venkat Pratap Reddy & family | 1,400 | MSN Laboratories | Pharmaceuticals |
22 | Manish Doshi & Family | 1,300 | Amoli Organics | Pharmaceuticals |
22 | Pallavi Bharat Mehta & family | 1,300 | J B Chemicals & Pharmaceuticals | Pharmaceuticals |
22 | Rajesh Kumar | 1,300 | Alkem Laboratories | Pharmaceuticals |
22 | Shirish Mody & family | 1,300 | J B Chemicals & Pharmaceuticals | Pharmaceuticals |
22 | Bharat Daftary & family | 1,200 | Bharat Serums & Vaccines | Pharmaceuticals |
22 | Gautam Daftary & family | 1,200 | Bharat Serums & Vaccines | Pharmaceuticals |
22 | Janmejay Rajnikant Vyas | 1,200 | Dishman Carbogen Amcis | Pharmaceuticals |
22 | Kishor Kumar Singh | 1,200 | Alkem Laboratories | Pharmaceuticals |
22 | Mohan Anand Chandavarkar & family | 1,200 | FDC | Pharmaceuticals |
22 | Nawal Kishore Singh | 1,200 | Alkem Laboratories | Pharmaceuticals |
22 | Prashant Malladi | 1,200 | Malladi Drugs & Pharmaceuticals | Pharmaceuticals |
22 | Rajeev Ranjan | 1,200 | Alkem Laboratories | Pharmaceuticals |
23 | Ashok Anand Chandavarkar & family | 1,100 | FDC | Pharmaceuticals |
23 | Mark Saldanha | 1,100 | Marksans Pharma | Pharmaceuticals |
23 | Meera Ramdas Chandavarkar & family | 1,100 | FDC | Pharmaceuticals |
23 | Sunil Sachdeva & family | 1,100 | Medanta Medicity | Healthcare |
23 | Yalavarthy Shyam Prasad & family | 1,100 | Laurus Labs | Pharmaceuticals |
24 | Alok Kumar | 1,000 | Alkem Laboratories | Pharmaceuticals |
24 | Arun Kumar Pillai | 1,000 | Sequent Scientific | Pharmaceuticals |
24 | Ashok Kumar | 1,000 | Alkem Laboratories | Pharmaceuticals |
24 | Deepak Kumar Singh | 1,000 | Alkem Laboratories | Pharmaceuticals |
24 | M Sivakumaran | 1,000 | Aurobindo Pharma | Pharmaceuticals |
24 | Nalla G Palaniswami & family | 1,000 | Kovai Medical Center & Hospital | Healthcare |
24 | Pranabh Mody & family | 1,000 | J B Chemicals & Pharmaceuticals | Pharmaceuticals |
24 | PVA Mohandas & family | 1,000 | MIOT Hospitals | Healthcare |
Commenting on the launch, Yatin Shah, Co-Founder & Joint CEO, IIFL Wealth, said, "IIFL Wealth Hurun India Rich List 2022, is a comprehensive overview of a plethora of factors that have significantly contributed to the rising wealth of India and we are proud to associate with the same. Despite the slump in the economy owing to geo-political challenges, volatility in global financial markets, and sharp spike in oil prices, India has successfully made an impression on the world's economy/wealth map. Pharmaceuticals, chemical & petrochemicals, IT, and financial services amongst others are some of the key sectors substantially contributing to wealth creation. It is exhilarating to see the entrepreneurial ecosystem of India contribute a significant amount to this list with the rising number of women entrepreneurs and uptick in self-made entrepreneurs. There are 65 founders of 37 unicorns along with 14 professional managers who have emerged as the cornerstone of wealth creation this time in the list."
Commenting on the launch, Anas Rahman Junaid, MD and Chief Researcher, Hurun India, said, "Post-pandemic, some of the COVID winners such as generic pharma, diagnostics, and Software & Services faced headwinds. While pharma and diagnostics dropped mainly on account of subdued demand post COVID, Software & Services industry has taken a beating due to fears of a recession in the developed markets that house most of the outsourcing clients."
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.